Robeco Institutional Asset Management B.V. purchased a new stake in shares of Analogic Co. (NASDAQ:ALOG) during the first quarter, Holdings Channel reports. The institutional investor purchased 13,260 shares of the medical research company’s stock, valued at approximately $1,272,000.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Princeton Capital Management LLC acquired a new position in shares of Analogic during the first quarter valued at approximately $175,000. Elkfork Partners LLC acquired a new position in shares of Analogic during the fourth quarter valued at approximately $157,000. Cornerstone Capital Management Holdings LLC. acquired a new position in shares of Analogic during the fourth quarter valued at approximately $167,000. Aperio Group LLC acquired a new position in shares of Analogic during the fourth quarter valued at approximately $218,000. Finally, Algert Global LLC acquired a new position in shares of Analogic during the first quarter valued at approximately $318,000. Institutional investors and hedge funds own 94.18% of the company’s stock.
NASDAQ ALOG opened at $83.65 on Friday. Analogic Co. has a 12 month low of $66.00 and a 12 month high of $101.80. The company has a market cap of $1.05 billion, a P/E ratio of 48.63, a P/E/G ratio of 2.83 and a beta of 0.64.
Analogic (NASDAQ:ALOG) last posted its quarterly earnings data on Monday, March 5th. The medical research company reported $1.27 EPS for the quarter, beating the Zacks’ consensus estimate of $0.69 by $0.58. The business had revenue of $129.20 million for the quarter, compared to analyst estimates of $112.50 million. Analogic had a negative net margin of 15.34% and a positive return on equity of 6.05%. The business’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter last year, the business earned $0.99 earnings per share. research analysts expect that Analogic Co. will post 4.23 EPS for the current fiscal year.
A number of research firms recently commented on ALOG. TheStreet lowered shares of Analogic from a “b-” rating to a “c” rating in a research note on Monday, May 14th. Zacks Investment Research lowered shares of Analogic from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 7th. BidaskClub upgraded shares of Analogic from a “strong sell” rating to a “sell” rating in a research note on Friday, March 30th. Finally, ValuEngine lowered shares of Analogic from a “buy” rating to a “hold” rating in a research note on Thursday, April 12th. One investment analyst has rated the stock with a sell rating and three have assigned a hold rating to the stock. Analogic presently has an average rating of “Hold” and a consensus price target of $94.00.
Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection.
Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.